Solid state characterization of domperidone: Hydroxypropyl-β- cyclodextrin inclusion complex

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 2, 2010, Pages 245-249

  Ghodke, D S ^a,b   Chaulang, G M ^a,b   Patil, K S ^a,b   Nakhat, P D ^a,b   Yeole, P G ^a,b   Naikwade, N S ^a,b   Magdum, C S ^a,b  

^a INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^b Appasaheb Birnale College of Pharmacy   (India)

Author keywords

Domperidone; HP b CD; inclusion complex

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DOMPERIDONE; HYDROCHLORIC ACID; WATER;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DETERMINATION; DRUG SOLUBILITY; FOURIER ANALYSIS; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; SOLID STATE; ULTRASOUND; X RAY DIFFRACTION;

EID: 77954855813     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.65032     Document Type: Article

References (14)

1. Sweetman SC. In: Martindale-The Complete Drug Reference. 33rd ed. London: Pharmaceutical Press; 2002. p. 1224.
2. Yap KL, Liu X, Thenmozhiyal JC. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci 2005;25:49-56.
3. Ventura CA, Giannone I, Musumeci T, Pignatello R, Ragni, L, Landolfi C et al. Physico-chemical characterization of disoxaril-dimethyl-P-cyclodextrin inclusion complex and in vitro permeation studies. Eur J Med Chem 2006;4:233-240
4. Fernandesa CM, Ramosb P, Baptista V. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits. J Control Release 2003;88:127-134
5. Ribeiro LS, Ferreira DC, Francisco JB, Veiga FJ, Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with P-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Biopharm 2003;20:253-266
6. Holvoet C, Vercammena JP, Heyden YV, Gabriels M, Camuc F. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia. Int J Pharm 2003;265:13-26.
7. Jambhekar S, Casella R, Mahera T. The physicochemical characteristics and bioavailability of indomethacin from P-cyclodextrin, hydroxyethyl-P- cyclodextrin, and hydroxypropyl-P-cyclodextrin complexes. Int J Pharm 2004;270:149-166
8. Liu X, Lin H, Thenmozhiyal JC, Chan S, Paul HC. Inclusion of acitretin into cyclodextrins: Phase solubility, Photostability, and physicochemical characterization. J Pharm Sci 2003;92:2449-2457
9. Mourya VK, Saini TR, Shete JS, Jadhav GS. Molecular inclusion of sparfloxacin with hydroxypropylbetacyclodextrin. Indian J Pharm Sci 2002;64:568-572
10. Liu L, Zhu S. Preparation and characterization of inclusion complexes of prazosin hydrochloride with cyclodextrin and hydroxypropyl- cyclodextrin J Pharm Biomed Anal 2006;40:122-127
11. Wen X, Tan F, Jing Z, Liu Z. Preparation and study the 1:2 inclusion complex of carvedilol with cyclodextrin. J Pharm Biomed Anal 2004;34:517-523
12. Cartensen, JT. Drug stability: Principle and Practice, 2nd ed. New York: Marcel Dekker: 1995. p. 538-550
13. Challa R, Ahuja A, Javed A, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;2:82-99.
14. Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Med Chem 2006;62:241-246